The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.675
Bid: 18.35
Ask: 19.00
Change: -0.075 (-0.40%)
Spread: 0.65 (3.542%)
Open: 18.75
High: 0.00
Low: 0.00
Prev. Close: 18.75
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Preliminary Results

10 Mar 2015 07:02

RNS Number : 9651G
BATM Advanced Communications Ld
10 March 2015
 

10 March 2015

 

BATM Advanced Communications Limited

("BATM" or the "Group")

 

Preliminary Results for 2014

 

BATM Advanced Communications Limited (LSE: BVC; TASE: BATM), a leading provider of real-time technologies for the networked telecoms and medical laboratory equipment markets, announces its preliminary results for the year ended 31 December 2014.

 

Financial Summary

Group revenues amounted to $109.2m (2013: $114.2m)Gross profit of $34.1m (2013: $39.6m)EBITDA of $0.9m (2013: $2.1m)Net loss for the year reduced to $3.2m (2013: $4.5m loss)In the second half of the year, inventory write-off of $1.6m, mostly attributable to the legacy Telecom productsAdverse foreign exchange impacted Medical division revenues in H2 2014Basic loss per share from continuing and discontinued operations of 0.79¢ (2013: 1.12¢ loss per share)As at 31 December 2014, the Group had cash and cash equivalents and financial assets of $34.9m (30 June 2014: $36.1m; 31 December 2013: $40.8m)

 

Operational Summary

Medical division (54% of total sales)

Distribution unit continued to grow sales in all territories in which it operates Substantial increase in capacity achieved by Pathogenic Waste Treatment Sterilisation unit in H2 2014, through moving into significantly larger facility, enabling it to deliver solid revenue growth in Q4 2014 Diagnostics unit received certifications of diagnostic kits in several new geographiesPost period-end, Diagnostics unit was granted a license by the China Food and Drug Administration of People's Republic of China for the importation, marketing and sale of its diagnostic kit for hepatitis C; and the unit is installing new equipment to enable it to substantially increase production capacity

 

Telecom division (46% of total sales)

Continued to implement the strategic change to focus on Tier 1 clients, SDN (Software Defined Networking) and NFV (Network Function Virtualisation) solutionsWon significant multi-year Access Carrier Ethernet contracts with two Tier 1 operators in the APAC regionAchieved a market first with the introduction of SDN support on its Network Access portfolio of productsSuccessfully launched the Open Metro Edge (OME) set of products to enable Network Virtual FunctionsIntroduced four virtual software functions - Firewall, Cloud Tunnelling, Router and Measurement Utility - thus solidifying its software-based offeringContinued roll out, together with Cisco Systems and Israeli Electric Company, of fibre optic project to create new fibre carrier in Israel to compete with the incumbent carrier, BezeqCELARE, the Group's cyber operation, signed a significant contract, in July 2014, with Oracle for offering integrated solution

 

Dr Zvi Marom, Chief Executive Officer of BATM, said:

 

"We are pleased that the Group made solid progress in both its divisions this year. The Medical division is now the dominant business whilst the Telecom division has stabilised and is recovering well. The underlying fundamentals of the businesses are sound and, were it not for the foreign exchange impact in reporting the results and the one-time write-off of the legacy business inventory, the numbers would have reflected the progress achieved in the year.

 

"Looking ahead, we believe that the momentum of the fourth quarter will continue into 2015, particularly in the Medical division. We expect the Medical division to achieve another year of solid growth with a greater number of products being delivered to more territories and increased cooperation with major industry players. In the Telecom division, we expect to start benefitting from contracts awarded in the second half of 2014. Consequently, the Board is confident of delivering improved results in 2015 compared with 2014."

 

 

Enquiries:

 

BATM Advanced Communications

 

Dr Zvi Marom, Chief Executive Officer

+972 9866 2525

Moti Nagar, Chief Financial Officer

 

 

 

finnCap

 

Stuart Andrews

+44 20 7220 0500

 

 

Shore Capital

 

Pascal Keane

+44 20 7408 4090 

 

 

Luther Pendragon

 

Harry Chathli, Claire Norbury

+44 20 7618 9100

 

 

 

 

 

Operational Review

 

In 2014, BATM continued to make solid progress in all its businesses and experienced a strong end to the year. In Q4 2014, the Group achieved sequential revenue growth over Q3 2014 of 20.0% to $28.7m. Revenues in the Medical division grew by 41.5% over Q3 2014, whilst revenues in the Telecom division remained stable. The Medical division contributed 54% of total sales and the Telecom division accounted for 46% of total 2014 sales.

 

These results reflect the momentum and progress that the Group has achieved in the Medical division during 2014. They also validate the management's strategic decision to focus on Tier 1 operators and to appoint new leadership at the Telecom division.

 

Medical Division

 

 

H1 2014

H2 2014

FY 2014

FY 2013

Revenues

$30.2m

$28.6m

$58.8m

$53.1m

Gross margin

23%

23%

23%

24%

Operating loss

$1.0m

$0.5m

$1.5m

$2.3m

 

The decline in revenues in the second half of the year was due to the impact of adverse foreign exchange, particularly the depreciation of the Moldavian lei - a significant territory for the Distribution unit - and Euro against the US Dollar (7.8% and 6.1% respectively). Without this, the revenues in the second half would have been in line with those of the first half of the year.

 

The Distribution unit contributed approximately 64.2% of Medical division revenues in 2014, and achieved annual revenue and profit growth over 2013. The Group expects continued growth in revenues and profit during 2015 in all of the geographies in which the Distribution unit operates.

 

The Pathogenic Waste Treatment Sterilisation unit constituted 17.4% of the Medical division's revenues and, significantly, continues to achieve operating profitability. The unit grew revenues by 15.2% while maintaining gross and operating margins. The business remains focused on the treatment of medical and biological waste, based on unique patented technology, and the expansion of its OEM relationships. During the fourth quarter, it launched a new version of a smaller steriliser designed for dialysis centres and laboratories, and had already supplied 40 devices by the end of the year. In addition, the Group continued to expand the applications of its biological waste solution, including for pharmaceutical plants.

 

The Diagnostics unit, which constituted 18.4% of Medical division revenues in 2014, made significant progress during the year in several respects. The business established new customer relationships and invested in automating production in order to increase capacity, which will enable the Group to target major customers and markets. Certification efforts continued, mainly in Latin America and the Far East, with certifications being granted post period-end, including being granted a license by the China Food and Drug Administration of People's Republic of China for the importation, marketing and sale in China of the Group's diagnostic kit for hepatitis C, which it identifies by detecting antibodies to the virus using an ELISA screen. To service the Chinese market, the business has established an office in Wushi, near Shanghai. In addition, the expansion in production capacity, through the installation of additional equipment, is anticipated to achieve a 50% increase in reagent production in 2015. The Group expects that these efforts made in 2014 will yield results in H1 2015.

 

 

 

Telecom Division

 

 

H1 2014

H2 2014

FY 2014

FY 2013

Revenues

$26.4m

$24.0m

$50.4m

$61.1m

Gross margin

45%

36%

41%

44%

Operating profit (loss)

$1.4m

$(0.9m)

$0.5m

$2.4m

 

The decline in revenues and gross margin in the second half of the year was due to lower revenue and a dead stock inventory write-off of $1.6m in the second half of the year mostly attributed to the legacy products.

 

As previously announced, in Q3 2014 the Group launched the CloudMetro™ 100, the world's first 10GE platform for virtualised IT services at the network edge. This marks further progress with the Group's new strategy of concentrating on Tier 1 clients, SDN (Software Driven Networks) and NFV (Network Function Virtualisation). The Group is one of the pioneering vendors to offer SDN support on its entire portfolio of products, positioning BATM as an SDN and NFV market leader. This achievement allows the Group to offer many advanced third party software applications on top of its newly created open network platform thereby enabling Worldwide Network Service Providers to extend their offering and revenues beyond the traditional Network connectivity. The Group believes that this technology leadership will enable it to reach strong sustained long-term growth.

 

By launching IBC (Israel Broadband Company) and securing its first paying customers, together with Cisco Systems and the Israel Electric Company, the Group continued its active leadership in the consortium for the construction of a new nationwide fibre optic infrastructure network in Israel.

 

BATM's cyber unit, CELARE, signed a collaboration agreement to integrate its cyber solution with the big data solution of Oracle, one of the world's largest software companies. A pilot contract from a major customer was awarded at the end of July 2014 for the integrated solution, which aims to identify unknown network threats using big data analytics and machine learning processes.

 

Financial Review

 

Total Group revenues in 2014 decreased to $109.2m (2013: $114.2m). Medical division revenues increased by 10.7% to $58.8m (2013: $53.1m) as a result of organic growth whilst Telecom division revenues decreased by 17.5% to $50.4m (2013: $61.1m).

 

The blended gross profit margin for the year was 31.2% (2013: 34.7%). The gross profit of the Medical division remained unchanged at 23% whilst the Telecom division gross profit decreased from 44% to 41% mostly due to a write-off of $1.9m of inventory.

 

Sales and marketing expenses were $15.2m (2013: $16.7m), representing 14.0% of revenue compared with 14.7% in 2013. The majority of the decrease was in the Telco unit of the Telecom division.

 

General and administrative expenses were $11.1m (2013: $10.9m), representing 10.2% of revenue, compared with 9.6% in 2013. This increase of $0.2m is mostly due to a one-time allowance for doubtful debts and severance costs in the Telecom division.

 

R&D investment in 2014 was $8.7m (2013: $11.8m). This decrease of $3.1m was primarily due to a change in the focus of R&D towards a new solution for Tier 1 service provider clients and also as a result of a higher contribution from the Israeli Chief Scientist (2014: $1.3m; 2013: $0.6m).

 

Other operating expenses include amortisation of other intangible assets of $1.7m compared with $3.0m in 2013(including $0.9m amortisation on Vigilant) and a write-off of $2.5m goodwill on Vigilant in 2013.

 

Net finance expenses were $0.9m (2013: $0.6m expense), comprising $0.7m interest on tax expenses due to final tax assessments for the years 2007-2012, which were agreed with the tax authorities at the beginning of 2015, $0.5m of finance costs as well as a loss of $0.2m on forward transactions, which were partially offset by $0.5m of interest income and gain on marketable securities.

 

Net income tax benefit was $0.1m (2013: $0.3m), comprising $0.2m corporate tax for the year partially offset by $0.3m change in net deferred tax. During 2013, part of Vigilant carry forward tax losses were recognised by the tax authorities as part of the BATM balance sheet.

 

Net loss after tax attributable to equity holders of the Group amounted to $3.2m (2013: $4.5m loss), resulting in a basic loss per share of 0.79¢ (2013: 1.12¢ loss).

 

The Group's balance sheet remains strong with cash and financial assets of $34.9m, a decrease of $1.2m compared with $36.1m as at 30 June 2014 and a decrease of $5.9m compared with $40.8m as at 31 December 2013. The decrease in cash balances during the second half of 2014 is mainly due to operating loss in the second half of the year.

 

Period end cash is comprised as follows: cash and deposits up to three months duration of $15.9m and short-term cash deposits up to one year of $19.0m.

 

Intangible assets and Goodwill decreased to $16.4m (31 December 2013: $18.2m). The decrease is due to the amortisation of $1.7m, which is reported in other operating expenses.

 

Investment in non-consolidated companies relates mostly to the investment of $5.3m in the construction of a new nationwide fibre network of which $1.6m is not yet paid and is recorded as a current liability in the balance sheet. In addition, at the end of the year, the IBC project was re-appraised by an external valuator and the value increased, resulting in a net gain on available-for-sale financial assets to the Group of $0.47m in 2014 (2013: nil).

 

Property, plant and equipment including investment property decreased to $22.9m (31 December 2013: $24.7m) due to depreciation of fixed assets. Post period-end, the Group sold a building in Kfar Netter for a consideration of $1.5m.

 

Total inventories increased from $23.1m at the end of 2013 to $24.2m at 31 December 2014 mainly due to growth in the Distribution unit in Moldova.

 

Trade and other receivables decreased to $31.0m from $33.6m at the end of 2013. Trade and other payables decreased to $28.0m from $29.8m at the end of 2013. The majority of the decrease in the inventory, accounts receivables and accounts payables is due to the decline in the operation of Anda, which was part of the legacy products.

 

Current Trading and Prospects

 

The Group experienced a strong end to 2014, particularly in the Medical division, which the management expects to continue throughout 2015.

 

Specifically, the BATM management expect the Medical division to benefit from the expansion of the Distribution unit in Hungary; the increase in deliveries of the smaller steriliser units to laboratories; and the installation of a biological pathogenic waste solution at a major pharmaceutical vendor at the beginning of this year with further installations anticipated for later in 2015. In addition, in the Diagnostics unit, production capacity has been expanded to achieve a 50% increase in reagent production in 2015. As a result, the Medical division is expected to grow in 2015.

 

The Telecom division, which underwent a major strategic shift, has stabilised and is receiving interest as well as initial sales from major industry players for its Software Driven Networking offering. The Group believes that this will continue to be the focus of the industry for the foreseeable future and it expects to benefit from this trend.

 

As a result, the Board is confident of delivering improved results in 2015 compared with 2014.

 

 

BATM ADVANCED COMMUNICATIONS LTD.

UNAUDITED CONSOLIDATED INCOME STATEMENTS

 

 

Year ended 31 December

 

2 0 1 4

2 0 1 3

 

US$ in thousands

 

 

 

Revenues

109,247

114,155

 

 

 

Cost of revenues

75,143

74,564

 

 

 

Gross profit

34,104

39,591

 

------------

------------

 Operating expenses

 

 

 

 

 

Sales and marketing expenses

15,243

16,746

 

 

 

General and administrative expenses

11,165

10,919

 

 

 

Research and development expenses

8,716

11,830

 

 

 

Other operating expenses

1,708

5,534

 

 

 

Total operating expenses

36,832

45,029

 

------------

------------

 Operating loss from continuing 06d dilutedued operationoperations

(2,728)

(5,438)

 

 

 

Finance income

510

256

Finance expenses 

(1,454)

(865)

 

 

 

Loss before tax

(3,672)

(6,047)

 

 

 

Income tax benefits

140

314

 

 

 

 Loss for the year from continuing operations

(3,532)

(5,733)

 

 

 

Profit for the year from discontinued operations

-

319

 

 

 

Loss for the year

(3,532)

(5,414)

 

 

 

Attributable to:

 

 

Owners of the Company

(3,176 )

(4,513 )

Non-controlling interests

(356)

(901)

 

 

 

 Loss for the year

(3,532)

(5,414)

 

 Earnings/(loss) per share (In cents):

 

 

From continuing and discontinued operations

Basic and Diluted

 

From continuing operations

Basic and Diluted

 

 

From discontinued operations

Basic and Diluted

 

 

 

 

 

 

 

(0.79)

 

 

(0.79)

 

 

 

-

 

(1.12)

 

 

(1.20)

 

 

 

(0.08)

     

BATM ADVANCED COMMUNICATIONS LTD.

UNAUDITEDCONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS)

 

 

Year ended 31 December

 

2 0 1 4

2 0 1 3

 

US$ in thousands

 

 

 

Loss for the year

Item that may be reclassified subsequently to profit or loss:

Net gain on available-for-sale financial assets

(3,532)

 

 

473

(5,414)

 

 

-

Exchange differences on translating foreign operations

 

(4,254)

1,717

Total Comprehensive loss for the year

(7,313)

(3,697)

 

Attributable to:

 

 

Owners of the Company

(7,037)

(2,331)

Non-controlling interests

(276)

(1,366)

 

 

 

(7,313)

(3,697)

BATM ADVANCED COMMUNICATIONS LTD.

UNAUDITEDCONSOLIDATED STATEMENTS OF FINANCIAL POSITION

 

 

31 December

 

2 0 1 4

2 0 1 3

 

US$ in thousands

 

 

 

 

Current assets

 

 

Cash and cash equivalents

15,940

13,812

Trade and other receivables

31,025

33,552

Financial assets

18,974

27,012

Inventories

Assets classified as held for sale

24,202

916

23,118

-

 

91,057

97,494

Non-current assets

 

 

Property, plant and equipment

20,250

20,860

Investment property

Goodwill

Other intangible assets

Available for sale investments carried at fair value

Investment accounted for using the equity method

Deferred tax asset

2,659

11,459

4,946

5,741

-

____5,990

3,802

12,096

6,089

3,585

598

___5,483

 

51,045

52,513

 

 

 

 

 

 

Total assets

142,102

150,007

Current liabilities

Short-term bank credit

Trade and other payables

Provisions

 

 

4,187

27,973

3,562 35,722

 

2,658

29,761

2,826

35,245

 

 

 

Non-current liabilities

Long-term liabilities

Deferred tax liabilities

 

4,983

1,174

 

5,690

1,339

Retirement benefit obligation

 

786 6,943

 1,028

 8,057

Total liabilities

42,665

43,302

Equity

 

 

Share capital

1,216

1,216

Share premium account

407,345

407,300

Reserves

(15,674)

(11,813)

 Accumulated deficit

(293,064)

(289,888)

Equity attributable to:

 

 

Owners of the Company

99,823

106,815

Non-controlling interest

(386)

(110)

Total equity

Total equity and liabilities

106,705

110,241

 

99,437

142,102

106,705

150,007

 

BATM ADVANCED COMMUNICATIONS LTD.

UNAUDITEDCONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

 

Year ended 31 December 2014

 

 

 

Share Capital

Share Premium Account

Translation reserve

 

Other

reserve

 

Accumulated

Deficit

 

Attributable to owners of the Parent

 

Non-Controlling Interests

 

Total

equity

 

US$ in thousands

Balance as at 1 January 2014

 

1,216

 

407,300

 

(11,478)

 

(335)

 

(289,888)

 

106,815

 

(110)

 

106,705

Exercise of share based options by employees

 

 

-

 

 

3

 

 

 

 

 

3

 

 

-

 

 

3

Recognition of share-based payments

 

 

 

42

 

 

 

 

 

42

 

 

-

 

 

42

Loss for the year

 

 

 

 

(3,176)

(3,176)

(356)

(3,532)

Comprehensive loss for the year

 

 

(4,334)

473

 

(3,861)

 

80

 

(3,781)

Total Comprehensive loss for the year

 

 

 

 

 

 

(4,334)

 

 

473

 

 

(3,176)

 

 

(7,037)

 

 

(276)

 

 

(7,313)

Balance as at 31 December 2014

 

 

 

 

1,216

 

407,345

 

(15,812)

 

138

 

(293,064)

 

99,823

 

(386)

 

99,437

            

BATM ADVANCED COMMUNICATIONS LTD.

UNAUDITEDCONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (cont.)

 

Year ended 31 December 2013

 

 

 

Share Capital

Share Premium Account

Translation reserve

 

Other

reserve

 

Accumulated

Deficit

 

Attributable to owners of the Parent

 

Non-Controlling Interests

 

Total

equity

 

US$ in thousands

Balance as at 1 January 2013

 

1,215

 

407,140

 

(13,660)

 

(335)

 

(285,375)

 

108,985

 

1,256

 

110,241

Exercise of share based options by employees

 

 

1

 

 

36

 

 

 

 

 

37

 

 

-

 

 

37

Recognition of share-based payments

 

 

 

124

 

 

 

 

 

124

 

 

-

 

 

124

 

Loss for the year

 

 

 

 

 

 

 

(4,513)

 

(4,513)

 

(901)

 

(5,414)

Comprehensive income for the year

 

 

2,182

 

 

 

2,182

 

(465)

 

1,717

Total Comprehensive income for the year

 

 

 

 

 

 

2,182

 

 

 

(4,513)

 

 

(2,331)

 

 

(1,366)

 

 

(3,697)

Balance as at 31 December 2013

 

 

1,216

 

407,300

 

(11,478)

 

(335)

 

(289,888)

 

106,815

 

(110)

 

106,705

          

 

BATM ADVANCED COMMUNICATIONS LTD.

UNAUDITEDCONSOLIDATED STATEMENT OF CASH FLOWS

 

 

 

 Year ended 31 December

 

 

 

 

 

2 0 1 4

2 0 1 3

 

 

 

 

 

US$ in thousands

 

 

 

 

 

 

 

 

 

Net cash from (used in) operating activities  (Appendix A)

(5,282)

634

 

 

-------------

-------------

 

Investing activities

 

 

 

 

Interest received

Proceeds on disposal of property, plant and equipment

Proceeds on disposal of financial assets carried at fair value through profit and loss

Proceeds on disposal of deposits

Proceeds on available for sale investments carried at fair value

150

293

240

32,556

133

89

111

442

6,142

-

 

Purchases of property, plant and equipment

Purchases of financial assets carried at fair value through profit and loss

Purchases of deposits

(1,788)

(157)

(24,946)

(1,680)

(6,341)

(23,582)

 

Investment in Available for sale investments

carried at fair value

Investment accounted for using the equity method

 

(408)

-

 

(3,548)

(598)

 

Net Cash outflow on acquisition of business combinations

(676)

(38)

 

Net cash from (used in) investing activities

5,397

(29,003)

 

 

-------------

-------------

 

Financing activities

 

 

 

 

Increase in short-term bank credit

478

62

 

Bank loan repayment

(1,427)

(2,190)

 

Bank loan received

2,537

1,323

 

Proceeds on issue of shares

3

37

 

Net cash from (used in) financing activities

1,591

(768)

 

 

-------------

-------------

 

Increase (decrease) in cash and cash equivalents

1,706

(29,137)

 

 

 

 

 

Cash and cash equivalents at the beginning of the year

13,812

42,686

 

 

 

 

 

Effects of exchange rate changes on the balance of cash held in foreign currencies

 

422

 

263

 

 

 

 

 

Cash and cash equivalents at the end of the year

15,940

13,812

 

 

 

 

 

 

 

BATM ADVANCED COMMUNICATIONS LTD.

APPENDICES TO UNAUDITED CONSOLIDATED STATEMENT OF CASH FLOWS

 

APPENDIX A

RECONCILIATION OF OPERATING LOSS FOR THE YEAR TO NET CASH

FROM (USED IN) OPERATING ACTIVITIES

 

Year ended 31 December

 

2 0 1 4

2 0 1 3

 

 

US$ in thousands

 

 

 

 

 

Operating loss from continuing operations

Adjustments for:

(2,728)

(5,119)

 

Amortisation of intangible assets

1,708

3,040

 

Impairment of intangible assets and goodwill

-

2,494

 

Depreciation of property, plant and equipment

1,883

2,031

 

Share based payments

42

124

 

Increase in retirement benefit obligation

91

72

 

Decrease in provisions

(77)

(75)

 

Operating cash flow before movements in working capital

919

2,567

 

Increase in inventory

(3,044)

(2,341)

 

Decrease (increase) in receivables

290

(844)

 

Increase (decrease) in payables

(3,314)

2,920

 

Cash generated by operations

(5,149)

2,302

 

Income taxes paid

(222)

(1,419)

 

Income taxes received

341

148

 

Interest paid

(252)

(397)

 

Net cash from (used in) operating activities

(5,282)

634

 

       

 

BATM ADVANCED COMMUNICATIONS LTD

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 1 - General

The preliminary results for the year ended 31 December 2014 and the comparative 2013 information will be presented in the full Annual Report in accordance with International Financial Reporting Standards ("IFRS").

 

Note 2 - Profit/(loss) per share

Profit/(loss) per share is based on the weighted average number of shares in issue for the year of 403,146,217 (2013: 403,039,724). The number used for the calculation of the diluted profit per share for the year (which includes the effect of dilutive stock option plans) is 403,146,217 shares (2013: 403,039,724).

 

Note 3 - Disposal group classified as held for sale

During June 2012, the Company entered into a MOU agreement to dispose of its older time division multiplexing (TDM) based products ("Legacy") business, which formed part of the Group's Telecom operations. This event, which was completed during the six month period ended 30 June 2013, is consistent with the Group's long-term policy to focus on growing the Carrier Ethernet portfolio.

 

During the first half of 2013, the Group completed the sale of the legacy business excluding one of the product lines that re-integrated back into the Group's portfolio. This product line was previously classified as discontinued operation.

 

Profit for the year from discontinued operations:

 

Year ended 31 December

2 0 1 4$'000s

2 0 1 3$'000s

Revenues

-

1,889

Expenses

-

1,570

Profit before tax

-

319

Tax expenses

-

-

Profit for the year

-

319

 

Cash flows from discontinued operations:

 

Year ended 31 December

2 0 1 4$'000s

2 0 1 3$'000s

Net cash inflows from operating activities

-

1,075

Net cash inflows from investing activities

-

-

Net cash outflows from financing activities

-

-

Net cash inflows

-

1,075

 

Earnings per share (in cents) from discontinued operations:

 

Year ended 31 December

2 0 1 4

2 0 1 3

Basic and Diluted

-

0.08

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR FMGGFLLMGKZM
Date   Source Headline
2nd May 20247:00 amRNSBATM selected for TB diagnostics programme
18th Apr 20247:00 amRNSBATM to deliver Edgility to new Tier 1 customer
8th Apr 20247:00 amRNSBATM awarded new Edgility contract from Cemex
3rd Apr 20247:00 amRNSAnnual Financial Report
26th Mar 20247:00 amRNSBATM receives $2.3m cyber security orders
12th Mar 20247:00 amRNSFull Year Results
29th Feb 20247:00 amRNSNotice of Results
2nd Jan 20247:00 amRNSTotal Voting Rights
30th Nov 20237:03 amRNSBlock Listing Application
27th Nov 20237:00 amRNSBlock Listing Interim Review
30th Oct 20237:00 amRNSBATM receives $3m cyber security order
23rd Oct 20237:00 amRNSADOR Diagnostics secures $7.5m investment
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20237:00 amRNSNew Edgility order for US Emergency Services
9th Oct 20237:00 amRNSResponse to recent developments in Israel
6th Sep 20237:00 amRNSBATM receives $3.4m cyber security contract
29th Aug 20237:00 amRNSInterim Results
13th Jul 202311:30 amRNSResult of AGM and Director Appointment
8th Jun 20237:00 amRNSNotice of Annual General Meeting
6th Jun 20237:00 amRNSCapital Markets Day
5th Jun 20237:00 amRNSNew contract win for Edgility
10th May 20232:30 pmRNSCapital Markets Day and Investor Presentation
17th Apr 20237:00 amRNSEdgility rollout progressing ahead of schedule
4th Apr 20233:30 pmRNSAnnual Financial Report
6th Mar 20237:00 amRNSFull Year Results
24th Feb 20237:00 amRNSNotice of Results
1st Feb 20237:00 amRNSAppointment of Chief Financial Officer
9th Jan 20237:00 amRNSBATM receives $26m cyber security order
3rd Jan 20233:30 pmRNSGrant of Options
21st Dec 202212:00 pmRNSResult of AGM
21st Dec 20227:00 amRNSTransaction in Own Shares and TVR
20th Dec 20227:00 amRNSTransaction in Own Shares and TVR
19th Dec 20227:00 amRNSTransaction in Own Shares and TVR
16th Dec 20227:00 amRNSTransaction in Own Shares and TVR
15th Dec 20227:00 amRNSTransaction in Own Shares and TVR
14th Dec 20227:00 amRNSTransaction in Own Shares and TVR
13th Dec 20227:00 amRNSTransaction in Own Shares and TVR
9th Dec 20227:00 amRNSTransaction in Own Shares and TVR
8th Dec 20227:00 amRNSTrading Update
25th Nov 20221:00 pmRNSBlock Listing Interim Review
24th Nov 20224:00 pmRNSNotice of Annual General Meeting
27th Oct 20227:00 amRNSADOR and BIOASTER to develop STI diagnostic tests
18th Oct 20227:00 amRNSMulti-year contract with CityFibre for Edgility
6th Oct 20227:00 amRNSDirectorate Changes
24th Aug 20227:00 amRNSInterim Results
19th Jul 20227:00 amRNSAppointment of CEO of ADOR Diagnostics
11th Jul 20227:00 amRNSBATM partners with CityFibre for Edgility
16th Jun 20224:36 pmRNSPrice Monitoring Extension
26th May 20227:00 amRNSBlock Listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.